Pharmaceutical compositions containing at least one of haloperidol, imipramine or trifluoroperazine

摘要

Pharmaceutical compounds for the treatment of patients which show symptoms of unspecified retarded maturity, such as Alzheimer's Disease and other diseases which have an origin in numeric anomalies, deletions or chromosomatic fragility. These compounds include specific non toxic quantities of, at least one of the following drugs:a) Haloperidol (4-(4-(4-Cholorophenol)-4-Hydroxy Piperidine)-1-(4-Fluorohenol)-1-Butanona;b) Imipramine (10,11-Dihydro-N,N-Dimetil-5H-Dibenz (b,f)- Flazepine-5-Propanamine;c) Trifluoperazine (10-(3-(4-Methyl-1-Piperazinil)-Propil)-2- Trifluoromethyl)-10H-Phenotiazine;